Clinical hyperthyroidism due to non-neoplastic inappropriate thyrotrophin secretion.

We report a case of hyperthyroidism due to inappropriate thyrotrophin (TSH) secretion in a patient with selective pituitary resistance to thyroid hormone action. Symptoms of hyperthyroidism in patients with this disorder are usually mild, implying some peripheral tissue resistance to the metabolic effects of thyroid hormone. Our patient had unusually severe symptoms, including marked weight loss and cardiac arrythmias which required carbimazole and beta-blocker therapy for control. Somatostatin was ineffective in suppressing TSH secretion. The introduction of sensitive thyrotrophin assays should facilitate the accurate diagnosis of TSH-induced hyperthyroidism and avoid inappropriate treatment.

[1]  A. Ruokonen,et al.  EFFECTS OF THYROID HORMONES (T4, T3), BROMOCRIPTINE AND TRIAC ON INAPPROPRIATE TSH HYPERSECRETION , 1988, Clinical endocrinology.

[2]  B. Weintraub,et al.  Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. , 1987, The New England journal of medicine.

[3]  J. Burrin,et al.  Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995). , 1986, Acta endocrinologica.

[4]  B. Scheithauer,et al.  Pituitary gland in hypothyroidism. Histologic and immunocytologic study. , 1985, Archives of pathology & laboratory medicine.

[5]  A. Toft,et al.  HYPERTHYROIDISM DUE TO A THYROTROPHIN‐SECRETING MICROADENOMA , 1983, Clinical endocrinology.

[6]  M. Cattaneo,et al.  Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC) , 1983, Journal of endocrinological investigation.

[7]  R. Fahlbusch,et al.  HYPERTHYROIDISM DUE TO A TSH SECRETING PITUITARY ADENOMA: CASE REPORT, TREATMENT AND EVIDENCE FOR ADENOMA TSH BY MORPHOLOGICAL AND CELL CULTURE STUDIES , 1983, Clinical endocrinology.

[8]  H. Gharib,et al.  The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism. , 1982, Mayo Clinic proceedings.

[9]  B. Weintraub,et al.  Inappropriate secretion of thyroid-stimulating hormone. , 1981, Annals of internal medicine.

[10]  A. Burger,et al.  The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects. , 1979, Acta endocrinologica.

[11]  B. Osborne,et al.  Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism. , 1978, The Journal of clinical endocrinology and metabolism.

[12]  B. Weintraub,et al.  Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". , 1975, The Journal of clinical investigation.

[13]  C. Emerson,et al.  Hyperthyroidism and excessive thyrotropin secretion. , 1972, The New England journal of medicine.

[14]  F. Maloof,et al.  Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma. , 1970, The New England journal of medicine.

[15]  A. Pinchera,et al.  Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. , 1989, The Journal of clinical endocrinology and metabolism.

[16]  P. Beck‐Peccoz,et al.  Inappropriate secretion of thyrotropin by the pituitary. , 1987, Hormone research.

[17]  E. Cerasi,et al.  Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. , 1982, The Journal of clinical endocrinology and metabolism.